...
首页> 外文期刊>Urology >Feedback microwave thermotherapy versus TURP/prostate enucleation surgery in patients with benign prostatic hyperplasia and persistent urinary retention: a prospective, randomized, controlled, multicenter study.
【24h】

Feedback microwave thermotherapy versus TURP/prostate enucleation surgery in patients with benign prostatic hyperplasia and persistent urinary retention: a prospective, randomized, controlled, multicenter study.

机译:良性前列腺增生和持续性尿retention留患者的反馈微波热疗与TURP /前列腺摘除术:一项前瞻性,随机,对照,多中心研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVES: To assess the clinical efficacy of ProstaLund Feedback Treatment (PLFT) using the CoreTherm device versus transurethral resection of the prostate (TURP) and prostate enucleation surgery. METHODS: We performed a prospective, randomized, controlled, multicenter study of 120 patients with symptomatic benign prostatic hyperplasia and persistent urinary retention requiring an indwelling catheter or clean intermittent catheterization. The primary efficacy variables were success in catheter removal and symptom improvement. RESULTS: Of the 120 patients, 79% and 88% were catheter free after PLFT and surgery, respectively. The bother score (quality-of-life question) decreased from 4.6 in both groups before treatment to 1.4 in the PLFT group and 0.8 in the surgery group at 6 months of follow-up. The peak urinary flow rate was 13.4 mL/s after PLFT and 18.0 mL/s after surgery. The mean catheterization time was 34 days in the PLFT group and 5 days in the surgery group. CONCLUSIONS: PLFT is an effective alternative to surgical treatment in this group of catheterized patients. The risk of severe complications is reduced using PLFT, and an excellent treatment option can thereby be offered to this high-risk patient group who earlier could be treated only with lifelong catheterization.
机译:目的:评估使用CoreTherm装置与经尿道前列腺电切术(TURP)和前列腺摘除术相比,进行ProstaLund反馈治疗(PLFT)的临床疗效。方法:我们对120例有症状的良性前列腺增生和持续尿retention留的患者进行了一项前瞻性,随机,对照,多中心研究,这些患者需要留置导管或进行清洁的间歇性导管插入术。主要疗效变量是成功去除导管和改善症状。结果:120例患者中,PLFT和手术后无导管的患者分别为79%和88%。随访6个月时,两组的治疗评分(生活质量问题)从治疗前的4.6降低到PLFT组的1.4和手术组的0.8。 PLFT后最高尿流速为13.4 mL / s,手术后最高尿流速为18.0 mL / s。 PLFT组的平均导管插入时间为34天,手术组的平均导管插入时间为5天。结论:PLFT是这组导管插入患者的有效替代手术治疗方法。使用PLFT可以降低严重并发症的风险,从而可以为该高危患者组提供出色的治疗选择,这些患者更早只能通过终身导管治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号